Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis

BACKGROUND: The benefits of pioglitazone in patients with type 2 diabetes mellitus (T2DM) after percutaneous coronary intervention (PCI) is unclear. OBJECTIVES: To evaluate the effect of pioglitazone on prevention of in-stent restenosis (ISR) in patients with T2DM after PCI. METHODS: All full-text p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shi-jie, Zhong, Zhao-shuang, Qi, Guo-xian, Shi, Li-ye, Chen, Ling, Tian, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862640/
https://www.ncbi.nlm.nih.gov/pubmed/27163676
http://dx.doi.org/10.1371/journal.pone.0155273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862640/
https://www.ncbi.nlm.nih.gov/pubmed/27163676
http://dx.doi.org/10.1371/journal.pone.0155273

Ejemplares similares